A panel of clinical pharmacists discussed strategies for mitigating toxicities across different multiple myeloma, lymphoma, and leukemia populations.
Tiba Al Sagheer, PharmD, BCOP, BCACP
Advertisement
Articles by Tiba Al Sagheer, PharmD, BCOP, BCACP
Advertisement
Latest Updated Articles
Navigating AE Management for Cellular Therapy Across Hematologic CancersPublished: August 11th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Finding a “Sweet Spot” for Smoldering Multiple Myeloma Management
2
FDA Clears Phase 3 Lacutamab Protocol in Cutaneous T-Cell Lymphomas
3
Identifying and Pursuing Optimization of ADC Treatment in Cancer
4
How Supportive Care Methods Can Improve Oncology Outcomes
5
